share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  2024/11/08 21:14

Moomoo AI 已提取核心訊息

Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
Titan Pharmaceuticals announced on November 6, 2024, that its Board of Directors has appointed current director Brynner Chiam as acting principal executive officer and acting principal financial officer. Chiam will maintain his position on the company's Board while serving in these dual roles. The company has initiated a search for a permanent CEO.Chiam, 47, brings over 20 years of experience as a tax consultant and practitioner. He currently serves as Tax Director at Black Chamber Management since November 2020, following his previous role as Director at Tricor Taxand from 2014 to 2020. He holds a Bachelor of Business Studies in Accountancy from Massey University and is a member of the Chartered Tax Institute of Malaysia. No additional compensation or employment agreement has been established for his new executive roles.
泰坦製藥於2024年11月6日宣佈,董事會已任命現任董事Brynner Chiam爲臨時首席執行官和臨時財務長。Chiam將在擔任這兩個職務的同時,繼續保留他在公司董事會的職位。公司已啓動尋找永久首席執行官的工作。現年47歲的Chiam擁有超過20年的稅務顧問和從業經驗。自2020年11月以來,他擔任Black Chamber Management的稅務總監,此前從2014年到2020年擔任Tricor Taxand的董事。他獲得了梅西大學的會計學學士學位,並且是馬來西亞特許稅務學院的成員。沒有爲他的新職務設定額外的薪酬或僱傭協議。
泰坦製藥於2024年11月6日宣佈,董事會已任命現任董事Brynner Chiam爲臨時首席執行官和臨時財務長。Chiam將在擔任這兩個職務的同時,繼續保留他在公司董事會的職位。公司已啓動尋找永久首席執行官的工作。現年47歲的Chiam擁有超過20年的稅務顧問和從業經驗。自2020年11月以來,他擔任Black Chamber Management的稅務總監,此前從2014年到2020年擔任Tricor Taxand的董事。他獲得了梅西大學的會計學學士學位,並且是馬來西亞特許稅務學院的成員。沒有爲他的新職務設定額外的薪酬或僱傭協議。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息